The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate
Open accessAbstract
Sphingosine 1-phosphate (S1P) influences heart rate, coronary artery caliber, endothelial integrity, and lymphocyte recirculation through five related high affinity G-protein-coupled receptors. Inhibition of lymphocyte recirculation by non-selective S1P receptor agonists produces clinical immunosuppression preventing transplant rejection but is associated with transient bradycardia. Understanding the contribution of individual receptors has been limited by the embryonic lethality of the S1P(1) knock-out and the unavailability of selective agonists or antagonists. A potent, S1P(1)-receptor selective agonist structurally unrelated to S1P was found to activate multiple signals triggered by S1P, including guanosine 5'-3-O-(thio)triphosphate binding, calcium flux, Akt and ERK1/2 phosphorylation, and stimulation of migration of S1P(1)- but not S1P(3)-expressing cells in vitro. The agonist also alters lymphocyte trafficking in vivo. Use of selective agonism together with deletant mice lacking S1P(3) receptor reveals that agonism of S1P(1) receptor alone is sufficient to control lymphocyte recirculation. Moreover, S1P(1) receptor agonist plasma levels are causally associated with induction and maintenance of lymphopenia. S1P(3), and not S1P(1), is directly implicated in sinus bradycardia. The sustained bradycardia induced by S1P receptor non-selective immunosuppressive agonists in wild-type mice is abolished in S1P(3)-/- mice, whereas S1P(1)-selective agonist does not produce bradycardia. Separation of receptor subtype usage for control of lymphocyte recirculation and heart rate may allow the identification of selective immunosuppressive S1P(1) receptor agonists with an enhanced therapeutic window. S1P(1)-selective agonists will be of broad utility in understanding cell functions in vitro, and vascular physiology in vivo, and the success of the chemical approach for S1P(1) suggests that selective tools for the resolution of function across this broad lipid receptor family are now possible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sphingosine-1-phosphate: an enigmatic signalling lipid
Spiegel, S., & Milstien, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1103 · Cited by 2,075
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Self-citationThe Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.-X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,149
Garcia, J. G. N., Liu, F., Verin, A. D., Birukova, A., Dechert, M. A., Gerthoffer, W. T., Bamberg, J. R., & English, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12450 · Cited by 886
Lysophospholipids--Receptor Revelations
Hla, T., Lee, M.-J., Ancellin, N., Paik, J. H., & Kluk, M. J. (2001) · Science · doi:10.1126/science.1065323 · Cited by 537
Role of the Sphingosine-1-Phosphate Receptor EDG-1 in PDGF-Induced Cell Motility
Hobson, J. P., Rosenfeldt, H. M., Barak, L. S., Olivera, A., Poulton, S., Caron, M. G., Milstien, S., & Spiegel, S. (2001) · Science · doi:10.1126/science.1057559 · Cited by 426
Murata, N., Sato, K., Kon, J., Tomura, H., YANAGITA, M., Kuwabara, A., Ui, M., & Okajima, F. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520809 · Cited by 407
G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation
Allende, M. L., Yamashita, T., & Proia, R. L. (2003) · Blood · doi:10.1182/blood-2003-02-0460 · Cited by 380
Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors
Kluk, M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00139-7 · Cited by 316
Signaling and biological actions of sphingosine 1-phosphate
Hla, T. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00046-x · Cited by 280
Ishii, I., Friedman, B., Ye, X., Kawamura, S., McGiffert, C., Contos, J. J. A., Kingsbury, M. A., Zhang, G., Brown, J. H., & Chun, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104441200 · Cited by 272
Self-citationBrinkmann, V., & Lynch, K. R. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00374-6 · Cited by 262
Ishii, I., Ye, X., Friedman, B., Kawamura, S., Contos, J. J. A., Kingsbury, M. A., Yang, A. H., Zhang, G., Brown, J. H., & Chun, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200137200 · Cited by 244
Self-citationGraeler, M., & Goetzl, E. J. (2002) · The FASEB Journal · doi:10.1096/fj.02-0548com · Cited by 230
Lysophospholipids and their G protein-coupled receptors in inflammation and immunity
Gräler, M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00152-x · Cited by 181
Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P
OHMORI, T., YATOMI, Y., OSADA, M., KAZAMA, F., TAKAFUTA, T., IKEDA, H., & OZAKI, Y. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00260-8 · Cited by 180
FTY720: ALTERED LYMPHOCYTE TRAFFIC RESULTS IN ALLOGRAFT PROTECTION
Brinkmann, V., Pinschewer, D. D., Feng, L., & Chen, S. (2001) · Transplantation · doi:10.1097/00007890-200109150-00002 · Cited by 169
Sphingosine-1-phosphate receptors and the development of the vascular system
Allende, M. C., & Proia, R. L. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00175-0 · Cited by 167
FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation
Brinkmann, V., Pinschewer, D., Chiba, K., & Feng, L. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01419-4 · Cited by 163
Agonist-modulated Targeting of the EDG-1 Receptor to Plasmalemmal Caveolae
Igarashi, J., & Michel, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003075200 · Cited by 160
Identification of Edg1 Receptor Residues That Recognize Sphingosine 1-Phosphate
Parrill, A. L., Wang, D.-A., Bautista, D. L., Brocklyn, J. R. V., Lőrincz, Z., Fischer, D. J., Baker, D. L., Liliom, K., Spiegel, S., & Tigyi, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007680200 · Cited by 157
Sphingosine 1-Phosphate and Isoform-specific Activation of Phosphoinositide 3-Kinase β
Igarashi, J., & Michel, T. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105628200 · Cited by 134
Immunosuppressant FTY720 inhibits thymocyte emigration
Yagi, H., Kamba, R., Chiba, K., Soga, H., Yaguchi, K., Nakamura, M., & Itoh, T. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200005)30:5<1435::aid-immu1435>3.0.co;2-o · Cited by 134
Cutting Edge: Suppression of T Cell Chemotaxis by Sphingosine 1-Phosphate
Gräler, M. H., Shankar, G., & Goetzl, E. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4084 · Cited by 129
Rosen, H., Alfonso, C., Surh, C. D., & McHeyzer‐Williams, M. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832725100 · Cited by 127
Self-citationCell Type-specific Localization of Human Cardiac S1P Receptors
Mazurais, D., Robert, P., Gout, B., Berrebi‐Bertrand, I., Laville, M.-P., & Calmels, T. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000507 · Cited by 120
Xie, J., Nomura, N., Koprak, S., Quackenbush, E. J., Forrest, M. J., & Rosen, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3662 · Cited by 116
Self-citationEgress: a receptor‐regulated step in lymphocyte trafficking
Rosen, H., Sanna, G., & Alfonso, C. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00068.x · Cited by 107
Self-citationBudde, K., Schmouder, R., Nashan, B., Brunkhorst, R. R., Lücker, P. W., Mayer, T., Brookman, L. J., Nedelman, J. R., Skerjanec, A., Böhler, T., et al. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00130.x · Cited by 102
FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression
Brinkmann, V., Chen, S., Feng, L., Pinschewer, D. D., Nikolova, Z. G., & Hof, R. (2001) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)02126-6 · Cited by 90
Lipid mediators of angiogenesis and the signalling pathways they initiate
English, D. K., Brindley, D. N., Spiegel, S., & Garcia, J. G. N. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00176-2 · Cited by 74
Lysophospholipids and the cardiovascular system
Karliner, J. S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00174-9 · Cited by 73
Sphingosine 1-phosphate pathway therapeutics: a lipid ligand–receptor paradigm
Rosen, H., & Liao, J. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00085-1 · Cited by 57
Self-citation
Cited by
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., & Burtin, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3248 · Cited by 1,273
Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs
Cyster, J. G. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115628 · Cited by 856
“Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
Takabe, K., Paugh, S. W., Milstien, S., & Spiegel, S. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07113 · Cited by 718
Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network
Rosen, H., & Goetzl, E. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1650 · Cited by 694
Self-citationFinding a way out: lymphocyte egress from lymphoid organs
Schwab, S. R., & Cyster, J. G. (2007) · Nature Immunology · doi:10.1038/ni1545 · Cited by 605
Metadata
- Authors
- Sanna, M. G., Liao, J., Jo, E., Alfonso, C., Ahn, M.-Y., Peterson, M. S., Webb, B., Lefebvre, S., Chun, J., Gray, N., & Rosen, H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 279
- Issue
- 14
- Pages
- 13839-13848
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2105192692
- Cited by
- 626
- References
- 34
- FWCI
- 14.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.